This bill adds a new section to the General Laws that defines "clinician-administered drug" and prohibits health benefit issuers and pharmacy benefit managers from refusing to authorize, approve, or pay for covered clinician-administered drugs and related services. It also prohibits them from imposing coverage or benefits limitations or requiring additional fees or penalties when obtaining clinician-administered drugs from a healthcare provider or pharmacy of choice. The bill also protects the patient's right to choose their provider or pharmacy for clinician-administered drugs.

Additionally, the bill adds a new section to the General Laws that prohibits health benefit issuers from requiring a specialty pharmacy to dispense clinician-administered medication directly to a patient for transport to a healthcare provider. It also allows health benefit issuers to offer, but not require, the use of a home infusion pharmacy or an external infusion site for the dispensing of clinician-administered drugs. The bill aims to ensure patient choice in the dispensing of clinician-administered drugs and would take effect upon passage.